Dendritic cell derived-exosomes: Biology and clinical implementations

Journal of Leukocyte Biology

Volumn 80, Issue 3, 2006, Pages 471-478

  Chaput, Nathalie ^a,b   Flament, Caroline ^a   Viaud, Sophie ^a   Taieb, Julien ^a   Roux, Stephan ^a   Spatz, Alain ^b   André, Fabrice ^a   LePecq, Jean Bernard ^c   Boussac, Muriel ^d   Garin, Jérôme ^d   Amigorena, Sebastian ^e   Théry, Clotilde ^e   Zitvogel, Laurence ^a  

^a INSERM   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Anosys Inc   (United States)

^d Centre d'Energie Atomique   (France)

^e INSTITUT CURIE   (France)

Author keywords

Clinical trial; Cytotoxic T lymphocytes; Nk cells; Tumor immunotherapy

Indexed keywords

CANCER VACCINE; CELL PROTEIN;

AUTOTRANSPLANTATION; CANCER IMMUNOTHERAPY; CANCER PATIENT; CELL COMPOSITION; CELL FUNCTION; CELL MATURATION; CELL TRANSPLANTATION; CLINICAL TRIAL; CYTOLOGY; DENDRITIC CELL; DENDRITIC CELL DERIVED EXOSOME; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LUNG NON SMALL CELL CANCER; MELANOMA; MEMBRANE VESICLE; METASTASIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; CANCER VACCINES; CLINICAL TRIALS, PHASE I; DENDRITIC CELLS; ENDOSOMES; HUMANS; IMMUNOTHERAPY; NEOPLASMS;

EQUIDAE;

EID: 33751504617     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0206094     Document Type: Review

References (60)

1. Fevrier, B., Raposo, G. (2004) Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 16, 415-421.
2. Stoorvogel, W., Kleijmeer, M. J., Geuze, H. J., Raposo, G. (2002) The biogenesis and functions of exosomes. Traffic 3, 321-330.
3. Thery, C., Zitvogel, L., Amigorena, S. (2002) Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569-579.
4. Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L., Turbide, C. (1987) Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262, 9412-9420.
5. Johnstone, R. M., Bianchini, A., Teng, K. (1989) Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions. Blood 74, 1844-1851.
6. Johnstone, R. M., Ahn, J. (1990) A common mechanism may be involved in the selective loss of plasma membrane functions during reticulocyte maturation. Biomed. Biochim. Acta 49, S70-S75.
7. Johnstone, R. M., Mathew, A., Mason, A. B., Teng, K. (1991) Exosome formation during maturation of mammalian and avian reticulocytes: evidence that exosome release is a major route for externalization of obsolete membrane proteins. J. Cell. Physiol. 147, 27-36.
8. Blanchard, N., Lankar, D., Faure, F., Regnault, A., Dumont, C., Raposo, G., Hivroz, C. (2002) TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/ζ complex. J. Immunol. 168, 3235-3241.
9. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., Amigorena, S. (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4, 594-600.
10. Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., Geuze, H. J. (1996) B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161-1172.
11. van Niel, G., Heyman, M. (2002) The epithelial cell cytoskeleton and intracellular trafficking. II. Intestinal epithelial cell exosomes: perspectives on their structure and function. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G251-G255.
12. Van Niel, G., Mallegol, J., Bevilacqua, C., Candalh, C., Brugiere, S., Tomaskovic-Crook, E., Heath, J. K., Cerf-Bensussan, N., Heyman, M. (2003) Intestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice. Gut 52, 1690-1697.
13. Taylor, D. D., Gercel-Taylor, C. (2005) Tumor-derived exosomes and their role in cancer-associated T-cell signaling defects. Br. J. Cancer 92, 305-311.
14. Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Thery, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., Angevin, E., Amigorena, S., Zitvogel, L. (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7, 297-303.
15. Riteau, B., Faure, F., Menier, C., Viel, S., Carosella, E. D., Amigorena, S., Rouas-Freiss, N. (2003) Exosomes bearing HLA-G are released by melanoma cells. Hum. Immunol. 64, 1064-1072.
16. Andre, F., Schartz, N. E., Chaput, N., Flament, C., Raposo, G., Amigorena, S., Angevin, E., Zitvogel, L. (2002) Tumor-derived exosomes: a new source of tumor rejection antigens. Vaccine 20 (Suppl. 4), A28-A31.
17. Andre, F., Schartz, N. E., Movassagh, M., Flament, C., Pautier, P., Morice, P., Pomel, C., Lhomme, C., Escudier, B., Le Chevalier, T., Tursz, T., Amigorena, S., Raposo, G., Angevin, E., Zitvogel, L. (2002) Malignant effusions and immunogenic tumor-derived exosomes. Lancet 360, 295-305.
18. Delcayre, A., Le Pecq, J. B. (2006) Exosomes as novel therapeutic nanodevices. Curr. Opin. Mol. Ther. 8, 31-38.
19. Lamparski, H. G., Metha-Damani, A., Yao, J. Y., Patel, S., Hsu, D. H., Ruegg, C., Le Pecq, J. B. (2002) Production and characterization of clinical grade exosomes derived from dendritic cells. J. Immunol. Methods 270, 211-226.
20. Thery, C., Regnault, A., Garin, J., Wolfers, J., Zitvogel, L., Ricciardi-Castagnoli, P., Raposo, G., Amigorena, S. (1999) Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J. Cell Biol. 147, 599-610.
21. Thery, C., Boussac, M., Veron, P., Ricciardi-Castagnoli, P., Raposo, G., Garin, J., Amigorena, S. (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166, 7309-7318.
22. Clayton, A., Court, J., Navabi, H., Adams, M., Mason, M. D., Hobot, J. A., Newman, G. R., Jasani, B. (2001) Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J. Immunol. Methods 247, 163-174.
23. Hemler, M. E. (2003) Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 19, 397-422.
24. Clayton, A., Harris, C. L., Court, J., Mason, M. D., Morgan, B. P. (2003) Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur. J. Immunol. 33, 522-531.
25. Katzmann, D. J., Odorizzi, G., Emr, S. D. (2002) Receptor downregulation and multivesicular-body sorting. Nat. Rev. Mol. Cell Biol. 3, 893-905.
26. Segura, E., Amigorena, S., Thery, C. (2005) Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol. Dis. 35, 89-93.
27. Segura, E., Nicco, C., Lombard, B., Veron, P., Raposo, G., Batteux, F., Amigorena, S., Thery, C. (2005) ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 106, 216-223.
28. Silvestre, J. S., Thery, C., Hamard, G., Boddaert, J., Aguilar, B., Delcayre, A., Houbron, C., Tamarat, R., Blanc-Brude, O., Heeneman, S., Clergue, M., Duriez, M., Merval, R., Levy, B., Tedgui, A., Amigorena, S., Mallat, Z. (2005) Lactadherin promotes VEGF-dependent neovascularization. Nat. Med. 11, 499-506.
29. Laulagnier, K., Motta, C., Hamdi, S., Roy, S., Fauvelle, F., Pageaux, J. F., Kobayashi, T., Salles, J. P., Perret, B., Bonnerot, C., Record, M. (2004) Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem. J. 380, 161-171.
30. Laulagnier, K., Grand, D., Dujardin, A., Hamdi, S., Vincent-Schneider, H., Lankar, D., Salles, J. P., Bonnerot, C., Perret, B., Record, M. (2004) PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes. FEBS Lett. 572, 11-14.
31. Laulagnier, K., Vincent-Schneider, H., Hamdi, S., Subra, C., Lankar, D., Record, M. (2005) Characterization of exosome subpopulations from RBL-2H3 cells using fluorescent lipids. Blood Cells Mol. Dis. 35, 116-121.
32. Hsu, D. H., Paz, P., Villaflor, G., Rivas, A., Mehta-Damani, A., Angevin, E., Zitvogel, L., Le Pecq, J. B. (2003) Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides. J. Immunother. 26, 440-450.
33. Thery, C., Duban, L., Segura, E., Veron, P., Lantz, O., Amigorena, S. (2002) Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat. Immunol. 3, 1156-1162.
34. Andre, F., Chaput, N., Schartz, N. E., Flament, C., Aubert, N., Bernard, J., Lemonnier, F., Raposo, G., Escudier, B., Hsu, D. H., Tursz, T., Amigorena, S., Angevin, E., Zitvogel, L. (2004) Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 172, 2126-2136.
35. Chaput, N., Schartz, N. E., Andre, F., Taieb, J., Novault, S., Bonnaventure, P., Aubert, N., Bernard, J., Lemonnier, F., Merad, M., Adema, G., Adams, M., Ferrantini, M., Carpentier, A. F., Escudier, B., Tursz, T., Angevin, E., Zitvogel, L. (2004) Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J. Immunol. 172, 2137-2146.
36. Aline, F., Bout, D., Amigorena, S., Roingeard, P., Dimier-Poisson, I. (2004) Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infect. Immun. 72, 4127-4137.
37. Sprent, J. (2005) Direct stimulation of naive T cells by antigen-presenting cell vesicles. Blood Cells Mol. Dis. 35, 17-20.
38. Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10, 942-949.
39. Ghiringhelli, F., Larmonier, N., Schmitt, E., Parcellier, A., Cathelin, D., Garrido, C., Chauffert, B., Solary, E., Bonnotte, B., Martin, F. (2004) CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur. J. Immunol. 34, 336-344.
40. Lutsiak, M. E., Semnani, R. T., De Pascalis, R., Kashmiri, S. V., Schlom, J., Sabzevari, H. (2005) Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 105, 2862-2868.
41. Taieb, J., Chaput, N., Schartz, N., Roux, S., Novault, S., Menard, C., Ghiringhelli, F., Terme, M., Carpentier, A. F., Darrasse-Jese, G., Lemonnier, F., Zitvogel, L. (2006) Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines. J. Immunol. 176, 2722-2729.
42. Kim, S. H., Lechman, E. R., Bianco, N., Menon, R., Keravala, A., Nash, J., Mi, Z., Watkins, S. C., Gambotto, A., Robbins, P. D. (2005) Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J. Immunol. 174, 6440-6448.
43. Kim, S. H., Bianco, N., Menon, R., Lechman, E. R., Shufesky, W. J., Morelli, A. E., Robbins, P. D. (2006) Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. Mol. Ther. 13, 289-300.
44. Peche, H., Heslan, M., Usal, C., Amigorena, S., Cuturi, M. C. (2003) Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 76, 1503-1510.
45. Andreola, G., Rivoltini, L., Castelli, C., Huber, V., Perego, P., Deho, P., Squarcina, P., Accornero, P., Lozupone, F., Lugini, L., Stringaro, A., Molinari, A., Arancia, G., Gentile, M., Parmiani, G., Fais, S. (2002) Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 195, 1303-1316.
46. Karlsson, M., Lundin, S., Dahlgren, U., Kahu, H., Pettersson, I., Telemo, E. (2001) "Tolerosomes" are produced by intestinal epithelial cells. Eur. J. Immunol. 31, 2892-2900.
47. Martinez-Lorenzo, M. J., Anel, A., Gamen, S., Monle, n., I., Lasierra, P., Larrad, L., Pineiro, A., Alava, M. A., Naval, J. (1999) Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J. Immunol. 163, 1274-1281.
48. Frangsmyr, L., Baranov, V., Nagaeva, O., Stendahl, U., Kjellberg, L., Mincheva-Nilsson, L. (2005) Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol. Hum. Reprod. 11, 35-41.
49. Gastpar, R., Gehrmann, M., Bausero, M. A., Asea, A., Gross, C., Schroeder, J. A., Multhoff, G. (2005) Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 65, 5238-5247.
50. Bausero, M. A., Gastpar, R., Multhoff, G., Asea, A. (2005) Alternative mechanism by which IFN-γ enhances tumor recognition: active release of heat shock protein 72. J. Immunol. 175, 2900-2912.
51. Clayton, A., Tabi, Z. (2005) Exosomes and the MICA-NKG2D system in cancer. Blood Cells Mol. Dis. 34, 206-213.
52. Escudier, B., Dorval, T., Chaput, N., Andre, F., Caby, M. P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., et al. (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J. Transl. Med. 3, 10.
53. Morse, M. A., Garst, J., Osada, T., Khan, S., Hobeika, A., Clay, T. M., Valente, N., Shreeniwas, R., Sutton, M. A., Delcayre, A., Hsu, D. H., Le Pecq, J. B., Lyerly, H. K. (2005) A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J. Transl. Med. 3, 9.
54. Patel, S., Mehta-Damani, A., Shu, H., Le Pecq, J. B. (2005) An analysis of variability in the manufacturing of dexosomes: implications for development of an autologous therapy. Biotechnol. Bioeng. 92, 238-249.
55. Borg, C., Terme, M., Taieb, J., Menard, C., Flament, C., Robert, C., Maruyama, K., Wakasugi, H., Angevin, E., Thielemans, K., et al. (2004) Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects. J. Clin. Invest. 114, 379-388.
56. Pages, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., Meatchi, T., Bruneval, P., Cugnenc, P. H., Trajanoski, Z., Fridman, W. H., Galon, J. (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 353, 2654-2666.
57. Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., Rubin, S. C., Coukos, G. (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348, 203-213.
58. Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., Coutant, F., Metivier, D., Pichard, E., Aucouturier, P., Pierron, G., Garrido, C., Zitvogel, L., Kroemer, G. (2005) Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J. Exp. Med. 202, 1691-1701.
59. Suhadolnik, R. J., Reichenbach, N. L., Hitzges, P., Adelson, M. E., Peterson, D. L., Cheney, P., Salvato, P., Thompson, C., Loveless, M., Muller, W. E., et al. (1994) Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome. In Vivo 8, 599-604.
60. Hayashi, T., Imai, K., Morishita, Y., Hayashi, I., Kusunoki, Y., Nakachi, K. (2006) Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance. Cancer Res. 66, 563-570.